Skip to content

Opening book details…

Can I read RIFM fragrance ingredient safety assessment, biphenyl, CAS Registry Number 92-52-4 on EtoBox?

RIFM fragrance ingredient safety assessment, biphenyl, CAS Registry Number 92-52-4 by A.M. Api; D. Belsito; D. Botelho; M. Bruze; G.A. Burton; M.A. Cancellieri; H. Chon; M.L. Dagli; M. Date; W. Dekant; C. Deodhar; A.D. Fryer; L. Jones; K. Joshi; M. Kumar; A. Lapczynski; M. Lavelle; I. Lee; D.C. Liebler; H. Moustakas; M. Na; T.M. Penning; G. Ritacco; J. Romine; N. Sadekar; T.W. Schultz; D. Selechnik; F. Siddiqi; I.G. Sipes; G. Sullivan; Y. Thakkar; Y. Tokura is a Medicine article available to read on EtoBox.

What is RIFM fragrance ingredient safety assessment, biphenyl, CAS Registry Number 92-52-4 about?

Abbreviation/Definition List: 2-Box Model -A RIFM, Inc. proprietary in silico tool used to calculate fragrance air exposure concentration AF -Assessment Factor BCF -Bioconcentration Factor CNIH -Confirmation of No Induction in Humans test. A human repeat insult patch test that is performed to confirm an already determined safe use level for fragrance ingredients (Na et al., 2021) Creme RIFM Model -The Creme RIFM Model uses probabilistic (Monte Carlo) simulations to allow full distributions of data sets, providing a more realistic estimate of aggregate exposure to individuals across a population (Comiskey et al., 2015, 2017; Safford et al., 2015a; Safford et al., 2017) compared to a deterministic aggregate approach DEREK -Derek Nexus is an in silico tool used to identify structural alerts DRF -Dose Range Finding DST -Dermal Sensitization Threshold ECHA -European Chemicals Agency ECOSAR -Ecological Structure-Activity Relationships Predictive Model EU -Europe/European Union GLP -Good Laboratory Practice IFRA -The International Fragrance Association LOEL -Lowest Observed Effect Level MOE -Margin of Exposure MPPD -Multiple-Path Particle Dosimetry. An in silico model for inhaled vapors u

Who reads RIFM fragrance ingredient safety assessment, biphenyl, CAS Registry Number 92-52-4?

It is typically read by researchers, students, and practitioners in Medicine.

Author
A.M. Api; D. Belsito; D. Botelho; M. Bruze; G.A. Burton; M.A. Cancellieri; H. Chon; M.L. Dagli; M. Date; W. Dekant; C. Deodhar; A.D. Fryer; L. Jones; K. Joshi; M. Kumar; A. Lapczynski; M. Lavelle; I. Lee; D.C. Liebler; H. Moustakas; M. Na; T.M. Penning; G. Ritacco; J. Romine; N. Sadekar; T.W. Schultz; D. Selechnik; F. Siddiqi; I.G. Sipes; G. Sullivan; Y. Thakkar; Y. Tokura
Publisher
Elsevier BV
Published
2022
Language
EN
Field
Medicine (Life Sciences)

More by A.M. Api; D. Belsito; D. Botelho; M. Bruze; G.A. Burton; M.A. Cancellieri; H. Chon; M.L. Dagli; M. Date; W. Dekant; C. Deodhar; A.D. Fryer; L. Jones; K. Joshi; M. Kumar; A. Lapczynski; M. Lavelle; I. Lee; D.C. Liebler; H. Moustakas; M. Na; T.M. Penning; G. Ritacco; J. Romine; N. Sadekar; T.W. Schultz; D. Selechnik; F. Siddiqi; I.G. Sipes; G. Sullivan; Y. Thakkar; Y. Tokura

Browse all works by A.M. Api; D. Belsito; D. Botelho; M. Bruze; G.A. Burton; M.A. Cancellieri; H. Chon; M.L. Dagli; M. Date; W. Dekant; C. Deodhar; A.D. Fryer; L. Jones; K. Joshi; M. Kumar; A. Lapczynski; M. Lavelle; I. Lee; D.C. Liebler; H. Moustakas; M. Na; T.M. Penning; G. Ritacco; J. Romine; N. Sadekar; T.W. Schultz; D. Selechnik; F. Siddiqi; I.G. Sipes; G. Sullivan; Y. Thakkar; Y. Tokura